Title: Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120701
Title: Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
Journal: Bioorganic & medicinal chemistry 20120315
Title: Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
Journal: Bioorganic & medicinal chemistry 20110815
Title: Choroid plexus transport: gene deletion studies.
Journal: Fluids and barriers of the CNS 20110101
Title: Oseltamivir (tamiflu) induced depressive episode in a female adolescent.
Journal: Psychiatry investigation 20101201
Title: Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090801
Title: Aurintricarboxylic acid inhibits influenza virus neuraminidase.
Journal: Antiviral research 20090201
Title: Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090201
Title: Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
Journal: Bioorganic & medicinal chemistry 20080401
Title: P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080201
Title: A QSAR study on influenza neuraminidase inhibitors.
Journal: Bioorganic & medicinal chemistry 20060215
Title: Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations.
Journal: Journal of medicinal chemistry 20031218
Title: In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.
Journal: Antiviral chemistry & chemotherapy 20030901
Title: Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
Journal: Biochemistry 20030128
Title: Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
Journal: Journal of virological methods 20021001
Title: In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
Journal: Journal of virology 20020601
Title: Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
Journal: Expert opinion on investigational drugs 20020601
Title: Structural studies of the resistance of influenza virus neuramindase to inhibitors.
Journal: Journal of medicinal chemistry 20020523
Title: In vitro and in vivo activities of anti-influenza virus compound T-705.
Journal: Antimicrobial agents and chemotherapy 20020401
Title: In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
Journal: Antimicrobial agents and chemotherapy 20020401
Title: The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20020101
Title: Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Journal: Antiviral research 20011201
Title: Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Journal: Antimicrobial agents and chemotherapy 20011201
Title: Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Journal: Antimicrobial agents and chemotherapy 20010401
Title: In vitro and in vivo assay systems for study of influenza virus inhibitors.
Journal: Antiviral research 20001001
Title: BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Journal: Journal of medicinal chemistry 20000921
Title: Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20000818
Title: Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
Journal: Bioorganic & medicinal chemistry letters 20000605
Title: Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 19990705
Title: Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
Journal: Antimicrobial agents and chemotherapy 19981201
Title: A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
Journal: Bioorganic & medicinal chemistry letters 19981201
Title: Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
Journal: Journal of medicinal chemistry 19980702
Title: GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains.
Journal: Biochemical and biophysical research communications 19980317
Title: Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Journal: Antimicrobial agents and chemotherapy 19980301
Title: Li W, et al. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother. 1998 Mar;42(3):647-53.
Title: Ghosh GC, et al. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ Health Perspect. 2010 Jan;118(1):103-7.
Title: Ferraris O, et al. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res. 2005 Oct;68(1):43-8.
Title: Gubareva LV, et al. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8.
Title: Yen HL, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis. 2005 Aug 15;192(4):665-72.
Title: Hoffmann G, et al. Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system. Antimicrob Agents Chemother. 2009 Nov;53(11):4753-61.
